Table: Chugai Pharm -6-MTH group results (IFRS)

Chugai Pharmaceutical

27/07/2023 08:00

Jul 27 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Dec 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              579.66              595.95                     
                   (-2.7 pct)                                       
  Operating          210.91              286.95                     
                   (-26.5 pct)         (+78.6 pct)                  
  Pretax
  Net                156.69              204.15                     
                   (-23.2 pct)         (+72.8 pct)                  
  EPS Basic         95.25 yen          124.14 yen                   
  EPS Diluted       95.23 yen          124.08 yen                   
  Ann Div                               78.00 yen        80.00 yen  
  -Q2 Div           40.00 yen           38.00 yen                   
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T